Worth reading
61In focus
Scored from 4 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Conditional
How definitive the wording is.Who is moving to which position
Resolved 22 April 2026Incoming appointee
1 itemScheduled Appointment DateLate June 2026. Formal decisions are scheduled to be made at the 22nd Annual General Meeting of Shareholders, scheduled for late June 2026, and at the subsequent meeting of the Board of Directors.
Suzuki Ryuji (鈴木 隆二)
New positionRepresentative Director and President
生年月日 31 August 1980所有株式数 ― shares (reference date: Not disclosed)
Departing officer
1 itemHashimoto Masamichi (橋本 征道)Next role stated
Former PositionRepresentative Director and President
New positionRepresentative director and chairman
“Next role stated” means the document names the position the person holds after stepping down. It does not necessarily mean they are leaving the company.
Whether the incumbent will remain in office (whether they will retain their position)
Will remain on the Board of Directors as Representative Director and Chairman
Shareholders’ meeting approvalRequired. The title of the proposed agenda item is Not disclosed. The 22nd Annual General Meeting of Shareholders is scheduled to be held in late June 2026.
Reason for change
To strengthen the management structure by welcoming a medical professional to the management team.
| Item | Details |
|---|---|
| Resolution date | 22 April 2026 |
| Scheduled Appointment Date | Late June 2026. Formal decisions are scheduled to be made at the 22nd Annual General Meeting of Shareholders, scheduled for late June 2026, and at the subsequent meeting of the Board of Directors. |
| Name of appointee | Suzuki Ryuji (鈴木 隆二) |
| Appointee's new position | Representative Director and President |
| Appointee's date of birth | 31 August 1980 |
| Number of shares held by the appointee | ― shares (reference date: Not disclosed) |
| Name of departing officer | Hashimoto Masamichi (橋本 征道) |
| Former position of departing officer | Representative Director and President |
| New position of departing officer | Representative director and chairman |
| Whether the incumbent will remain in office | Will remain on the Board of Directors as Representative Director and Chairman |
| Reason for change | To strengthen the management structure by welcoming a medical professional to the management team. |
| Subject to Approval by the General Meeting of Shareholders | Required. The title of the proposed agenda item is Not disclosed. The 22nd Annual General Meeting of Shareholders is scheduled to be held in late June 2026. |
Items this document does not state (9)
Date of departureAppointee's previous positionYear the appointee joined the CompanyReason for departureReasons for appointmentNumber of directors after the changeFiling as an independent officerDetails of organizational changesChange in Corporate Governance Structure
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To strengthen the management structure by welcoming a medical professional to the management team.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.